title: Minimal change disease and lenalidomide.
authors.affiliation: Hôpital Tenon, Paris, France.
authors.forename: Matthieu
authors.initials: M
authors.lastname: Jamme
authors.forename: Pierre
authors.initials: P
authors.lastname: Galichon
authors.forename: Alexandre
authors.initials: A
authors.lastname: Hertig
mesh_terms: D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects*; D000077269:Lenalidomide; D008297:Male; D008875:Middle Aged; D009402:Nephrosis, Lipoid / Q000139:chemically induced*; D013792:Thalidomide / Q000009:adverse effects / Q000031:analogs & derivatives*
chemical_list: D007155:Immunologic Factors; D013792:Thalidomide; D000077269:Lenalidomide